StonvexLoading…
StonvexStonvexStonvexCore line items from FBIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q3 2023 2023-07-01 | Q2 2023 2023-04-01 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 |
|---|---|---|---|---|---|
Revenue | $1.19B | $2.20B | $1.04B | $6.08B | $2.40B |
Operating Income | Not available | $284.40M | $131.80M | $592.00M | $399.30M |
Net Income | Not available | $186.70M | $84.60M | $577.10M | $372.90M |
EPS (Diluted) | $0.87 | $1.46 | $0.66 | $4.37 | $2.80 |
Total Assets | Not available | $6.87B | $5.97B | $8.42B | $8.33B |
Total Liabilities | Not available | $4.70B | $3.89B | $5.39B | $5.38B |
Cash & Equivalents | Not available | $681.70M | $539.10M | $345.30M | $360.60M |
Free Cash Flow OCF − CapEx | Not available | $391.40M | $33.50M | $113.70M | $-73.70M |
Shares Outstanding | Not available | 128.00M | 128.50M | 132.00M | 133.00M |